Vanda Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $2.86M, a 12.5% decline year-over-year.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $12.4M, a 11.5% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.4M, a 11.5% decline from 2023.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 13.8% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.3M, a 5.89% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.4M -$1.61M -11.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $14M -$2.24M -13.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $16.3M +$905K +5.89% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 $15.4M +$2.01M +15.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $13.4M -$98K -0.73% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $13.5M +$1.79M +15.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $11.7M +$1.2M +11.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $10.5M +$1.92M +22.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $8.54M +$582K +7.31% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $7.96M +$2.08M +35.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $5.88M +$474K +8.77% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $5.4M +$378K +7.52% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $5.03M -$460K -8.39% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 $5.49M +$679K +14.1% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $4.81M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.